Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/119066
Title: | Editorial : oligomers in amyloid-associated diseases—structural properties and toxicity |
Authors: | Vassallo, Neville Ongeri, Sandrine De Simone, Alfonso |
Keywords: | Amyloid Nervous system -- Degeneration Toxicity testing Oligomers Nervous system -- Diseases |
Issue Date: | 2023 |
Publisher: | Frontiers Research Foundation |
Citation: | Vassallo, N., Ongeri, S., & De Simone, A. (2023). Editorial : Oligomers in amyloid-associated diseases—structural properties and toxicity. Frontiers in Molecular Biosciences, 10, 1215340. |
Abstract: | The so-called “amyloid proteinopathies” represent a constellation of human diseases associated with the pathological formation and deposition of aberrant insoluble protein aggregates. They include neurodegenerative conditions such as Alzheimer’s, Parkinson’s and Huntington’s diseases, amyotrophic lateral sclerosis, and prion diseases; but may also involve organs and tissues outside the central nervous system, for instance the pancreas in type-2 diabetes mellitus. Collectively, amyloid-associated disorders affect around 50 million people each year worldwide and no cure is essentially known to stop the underlying molecular mechanisms of their origin. These conditions therefore generate significant burden on individuals, societies and healthcare budgets, and there is a burgeoning need for the rational development of effective therapeutic strategies. |
URI: | https://www.um.edu.mt/library/oar/handle/123456789/119066 |
ISSN: | 2296889X |
Appears in Collections: | Scholarly Works - FacM&SPB |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Editorial__Oligomers_in_amyloid-associated_diseases—structural_properties_and_toxicity(2023).pdf | 519.4 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.